A strategic external communications partner building the brands of an elite group of life sciences companies
Capabilities
- Executive Counsel
- Message Development/Refinement
- Corporate Communications
- Unparalleled Media Relations
- Executive Visibility & Speaking Opportunities
- Investor Relations & Capital Markets Advisory
- Presentation & Media Training
- Crisis Management
- Digital, Creative & Social Media Strategy
- Website & Brand Development
WE WORK WITH CLIENTS THROUGH MANY PHASES AND EXPERIENCES
- Company launches, private companies, publicly traded companies
- Financings, business development agreements, IPOs/reverse mergers, M&A
- Every phase of drug/device development, medical meeting and journal publication
- Drug/product approval (in U.S. and abroad), launch and commercial support
- Navigating various moments of adversity – clinical trial setbacks, FDA advisory committee meetings, approvable letters/CRLs, and unfortunately, many more!
STAT - ARCH Venture Partners: Q&A with Kristina Burow
The Economist: Neumora and Alector:: Better brain biology will deliver better medicines
Barron's: a16z: Healthcare Learned a Lot From Covid. 12 Ways to Invest Now.
STAT - Relay Therapeutics: Relay Therapeutics drug shows promise in early trial